Cargando…
Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the elderly, affecting 1 in 20 adults over the age of 70 years. Stroke is a major yet highly preventable complication of AF, and the strokes related to AF often are disabling and fatal. Warfarin is the treatment of choice in high-risk...
Autores principales: | Abcede, Hermelinda G., Ovbiagele, Bruce |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860552/ https://www.ncbi.nlm.nih.gov/pubmed/20461116 http://dx.doi.org/10.1007/s11936-010-0069-6 |
Ejemplares similares
-
Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
por: Bruce, Nhu T., et al.
Publicado: (2011) -
Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation
por: Polymeris, Alexandros A, et al.
Publicado: (2022) -
The Role of Hospitalists in the Acute Care of Stroke Patients
por: Amin, Alpesh, et al.
Publicado: (2010) -
Principled Versus Statistical Thinking in Diagnosis and Treatment of Stroke
por: Helgason, Cathy M., et al.
Publicado: (2010) -
Functional Outcome Measures of Recombinant Tissue Plasminogen
Activator–Treated Stroke Patients in the Telestroke Technology
por: Gainey, Jordan, et al.
Publicado: (2018)